Leptin

What is Leptin?

Leptin is a hormone made by fat cells that tells your brain roughly how much energy your body has stored.

Fat cells release leptin into your bloodstream in rough proportion to how much fat tissue you're carrying. The hormone travels to your hypothalamus, the part of the brain that governs hunger and energy use, and signals that stores are adequate, which normally dampens appetite. Researchers first mapped this pathway in mice with a mutation in the *ob* gene: the animals overate constantly and grew to roughly three times normal size until they received synthetic leptin, which reduced their food intake within days. Jeffrey Friedman at Rockefeller University identified the gene and its hormone product in 1994, work that later earned a share of the 2010 Lasker Award. In most cases of obesity, leptin is high, not low, because there's more fat tissue producing it. The brain often stops responding normally to that signal, a state generally called leptin resistance. Proposed mechanisms include impaired transport of leptin across the blood-brain barrier and blunted signaling downstream of the leptin receptor, though the exact chain of events is still being worked out (StatPearls, 2023; Cell Metabolism, 2025). A separate, rare condition runs the opposite direction: congenital leptin deficiency, caused by mutations in the *LEP* gene itself or its receptor. People with the complete form make little or no leptin and experience intense, constant hunger from early childhood, along with severe obesity and related hormonal effects (StatPearls, 2023). Metreleptin, sold as Myalept in the United States, is an FDA-approved synthetic leptin replacement, but its approved use is for generalized lipodystrophy, a different condition marked by an inability to store fat normally, not for common obesity (FDA label, 2014).

Typical reference context

Reference ranges for leptin vary by lab, by assay, and by body fat percentage, since the hormone scales with fat mass rather than sitting at one fixed "normal" number for every adult. There's no single screening cutoff used to diagnose obesity or metabolic disease from a leptin value alone, and most labs still describe its main clinical use as narrow: ruling in or out the rare congenital deficiency, not routine metabolic screening (Cleveland Clinic, 2025; StatPearls, 2023).

What changed recently

A 2025 study in *Pharmaceuticals* followed 32 adults with obesity through 12 weeks of submaximal-dose semaglutide alongside diet and activity changes. Median leptin fell from 24.6 ng/mL to 14.1 ng/mL, a drop of roughly 43%, tracking the fat loss participants experienced; the authors noted this pattern is consistent with partial restoration of leptin sensitivity as fat mass drops, though the study didn't measure adiponectin (Kosowska et al., *Pharmaceuticals*, September 2025). This adds a genuinely current data point on how GLP-1 receptor agonist therapy relates to circulating leptin in a study population. It's a research finding, not a treatment suggestion, and it doesn't tell you what any individual's own leptin trajectory would look like.

Tests often checked alongside this

• Adiponectin — the marker that moves in the opposite direction, generally falling as fat mass rises rather than rising with it, which is why the two are often discussed as a pair.
• Fasting insulin or HOMA-IR — leptin resistance and insulin resistance often appear together.
• Fasting glucose or HbA1c — gives longer-range context on glucose handling that a single leptin value doesn't provide.
• Lipid panel — congenital leptin deficiency and lipodystrophy syndromes both commonly involve abnormal triglycerides and cholesterol.

What can affect this marker

• Total body fat mass: the single strongest driver, since fat cells are the primary source of circulating leptin.
• Recent, large changes in body weight: leptin can shift within days to weeks of significant fat loss or gain, faster than fat mass itself is usually reassessed.
• Sex: for a given amount of fat mass, levels tend to run higher in women than in men.
• Acute illness or severe calorie restriction: short-term inflammation and fasting can lower leptin independent of fat mass changes.
• Sleep duration: shorter sleep has been associated with lower circulating leptin in research settings.

What to track over time

• The date and lab for each leptin result, since reference ranges differ between labs and assays.
• Body weight or fat measurements taken around the same time.
• Any period of rapid weight change in the weeks before a test.
• Related results ordered at the same visit, such as adiponectin, insulin, or a lipid panel.

What to ask your doctor

• What was this leptin test ordered to look for in my case?
• How does this lab's reference range compare to the one my last result used?
• Does my result, in context with my other labs, warrant any follow-up testing?
• If a lipodystrophy or congenital deficiency is being considered, what would the next steps look like?
• Should I track this alongside adiponectin or insulin at future visits?

This glossary entry is for informational purposes only and is not a substitute for professional medical advice. Read our Terms of Use.

Frequently asked questions